The effect of curcumin on corneal neovascularization in rabbit eyes

Current Eye Research

Volumn 35, Issue 4, 2010, Pages 274-280

  Kim, Jung Sub ^a   Choi, Jun Sub ^b   Chung, Sung Kun ^a  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cornea; Curcumin; Neovascularization; NF kappaB; VEGF

Indexed keywords

BALANCED SALT SOLUTION; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORNEA; CORNEA NEOVASCULARIZATION; IMMUNOFLUORESCENCE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADMINISTRATION, TOPICAL; ANGIOGENESIS INHIBITORS; ANIMALS; CORNEAL NEOVASCULARIZATION; CURCUMIN; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); NF-KAPPA B; OPHTHALMIC SOLUTIONS; RABBITS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77950798723     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713680903528345     Document Type: Article

References (35)

1. Chang JH, Gabison EE, Kato T, et al. Corneal neovascularization. Curr Opin Ophthalmol. 2001;12:242-249.
2. Cursiefen C, Kuchle M, Naumann GO. Angiogenesis in corneal diseases: Histopathologic evaluation of 254 human corneal buttons with neovascularization. Cornea. 1998;17:611-613.
3. Phillips K, Arffa R, Cintron C. Effect of prednisolone and medroxy progesterone on corneal wound healing, ulceration, and neovascularization. Arch Ophthalmol. 1983;101:640-643.
4. Crum R, Szabo S, Folkman J. A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science. 1986;230:1375-1378.
5. Murata M, Shimizu S, Houriuchi S, et al. Inhibitory effect of triamcinolone acetonide on corneal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2006;244:205-209.
6. Hayness WL, Proia AD, Klintworth GK. Effect of inhibitors of arachidonic acid metabolism on corneal neovascularization in the rat. Invest Ophthalmol Vis Sci. 1989;30:1588-1593.
7. Benelli U, Ross JR, Nardi M, et al. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci. 1997;38:274-282.
8. Primbs GB, Casey R, Wamser K, et al. Photodynamic therapy for corneal neovascularization. Ophthalmic Surg Lasers. 1998;29:832-838.
9. Yoon KC, You IC, Kang IS, et al. Photodynamic therapy with verteporfin for corneal neovascularization. Am J Ophthalmol. 2007;144:390-395.
10. Mendelsohn AD, Stock EL, Lo GG, et al. Laser photocoagulation of feeder vessels in lipid keratopathy. Ophthalmic Surg. 1986;17:502-508.
11. Shao C, Sima J, Zhang SX, et al. Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Invest Ophthalmol Vis Sci. 2004;45:1758-1762.
12. Frucht-Pery J, Siganos CS, Solomon A, et al. Limbal cell autograft transplantation for severe ocular surface disorders. Graefes Arch Clin Exp Ophthalmol. 1998;236:582-587.
13. Amano S, Rohan R, Kuroki M, et al. Requirement for vascular endothelial growth factor in wound-and inflammationrelated corneal neovascularization. Invest Ophthalmol Vis Sci. 1998;39:18-22.
14. Edelman JL, Castro MR, Wen Y. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol Vis Sci. 1999;40:1112-1123.
15. Karin M. Nuclear factor-kappaB in cancer development and progression. Nature. 2006;441:431-436.
16. Chariot A, Meuwis MA, Bonif M, et al. NF-kappaB activating scaffold proteins as signaling molecules and putative therapeutic targets. Curr Med Chem. 2003;10:593-602.
17. De Martin R, Hoeth M, Hofer-Warbinek R, et al. The transcription factor NF kappa B and the regulation of vascular cell function. Arterioscler Thromb Vasc Biol. 2000;20:83-88.
18. Josko J, Mazurek M. Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit. 2004;10:89-98.
19. Tong Q, Zheng L, Lin L, et al. VEGF is upregulated by hypoxia-induced mitogenic factor via the PI-3K/Akt-NFkappaB signaling pathway. Respir Res. 2006;7:37.
20. Araujo CC, Leon LL. Biological activities of Curcuma longa. Mem Inst Oswaldo Cruz. 2001;96:723-728.
21. Menon LG, Kuttan R, Kuttan G. Inhibition of lung metastasis in mice induced by B16F10 melanoma cells by polyphenolic compounds. Cancer Lett. 1995;95:221-225.
22. Phan TT, See P, Lee ST, et al. Protective effects of curcumin against oxidative damage on skin cells in vitro: Its implication for wound healing. J Trauma. 2001;51:927-931.
23. Bierhaus A, Zhang Y, Quehenberger P, et al. The dietary pigment curcumin reduces endothelial tissue factor gene expression by inhibiting binding of AP-1 to the DNA and activation of NF-kappa B. Thromb Haemost. 1997;77;772-782.
24. Singh S, Aggarwal BB. Activation of transcription factor NFkappa B is suppressed by curcumin (diferuloylmethane). J Biol Chem. 1995;270:24995-25000
25. Jobin C, Bradham CA, Russo MP, et al. Curcumin blocks cytokine-mediated NF-kappa B activation and proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;163:3474-3483.
26. Wang Y, Zhang MC, Hu YZ, et al. Inhibition of rat corneal neovascularization by inhibitor of nuclear factor-kappaB. Zhonghua Yan Ke Za Zhi. 2005;41:1124-1128.
27. Maheshwari RK, Singh AK, Gaddipati J, et al. Multiple biological activities of curcumin: A short review. Life Sci. 2006;78:2081-2087.
28. Arbiser JL, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998;4:376-383.
29. Gururaj AE, Belakavadi M, Venkatesh DA, et al. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun. 2002;297:934-942.
30. Kunnumakkara AB, Guha S, Krishnan S, et al. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB regulated gene products. Cancer Res. 2007;67:3853-3861.
31. Lin YG, Kunnumakkara AB, Nair A, et al. Curcumin inhibits tumor growth and angiogenesis in ovarian carcinoma by targeting the nuclear factor-kappaB pathway. Clin Cancer Res. 2007;13:3423-3430.
32. Okamoto T, Yamagishi S, Inagaki Y, et al. Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin. FASEB. 2002;16:1928-1930.
33. Bian F, Zhang MC, Zhu Y. Inhibitory effect of curcumin on corneal neovascularization in vitro and in vivo. Ophthalmologica. 2008;222:178-186.
34. Mohan R, Sivak J, Ashton P, et al. Curcuminoids inhibit the angiogenic response stimulated by fibroblast growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol Chem. 2000;275:10405-10412.
35. Kunwar A, Barik A, Mishra B, et al. Quantitative cellular uptake, localization and cytotoxicity of curcumin in normal and turmor cells. Biochim Biophys Acta. 2008: 1780:673-679.